Wed, 21st Oct 2020 17:50
BRASILIA, Oct 21 (Reuters) - Brazilian health authority
Anvisa said on Wednesday that a volunteer in a clinical trial of
the COVID-19 vaccine developed by AstraZeneca and Oxford
University has died, stating it had received data from an
investigation into the matter.
The Federal University of Sao Paulo, which is helping
coordinate phase 3 clinical trials in Brazil, separately said
that the volunteer was Brazilian.
(Reporting by Eduardo Simoes and Jake Spring; Editing by
Christian Plumb)
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
Astrazeneca (AZN)